-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Conoa-B (02162.HK) issued an announcement. Conoah and multinational pharmaceutical company Aeira Pte. Ltd. (Aeira) signed an exclusive licensing agreement. The two sides will cooperate on the marketing registration and commercialization of Spuchibimab Injection (trade name: Kangyueda®), a monoclonal antibody targeting IL-4Rα developed independently by Connoah in Southeast Asia and Central Asia.

Zhitongcaijing·09/02/2026 13:09:11
Listen to the news
Zhitong Finance App News, Conoa-B (02162.HK) issued an announcement. Conoah and multinational pharmaceutical company Aeira Pte. Ltd. (Aeira) signed an exclusive licensing agreement. The two sides will cooperate on the marketing registration and commercialization of Spuchibimab Injection (trade name: Kangyueda®), a monoclonal antibody targeting IL-4Rα developed independently by Connoah in Southeast Asia and Central Asia.